Searched for
SRINIVAS SADU
Gland Pharma appoints Shyamakant Giri as new CEOShyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of experience in t...
Gland Pharma Q1 profit dips 26% to Rs 144 croreGland Pharma on Tuesday said its profit after tax declined by 26 per cent to Rs 144 crore for the first quarter ended June 30, 2024. The Hy...
Gland Pharma Q4 Results: Net profit more than doubles to Rs 192.4 croreThe company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.
How Glenmark, Gland Pharma are reducing carbon emissions & increasing supply chain transparencyWith increased focus on sustainability, the domestic pharma firms are advancing their energy efficiency throughout their operational spectr...
Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...
Gland Pharma net profit down 72% to Rs 79 crore in Q4FY23Gland Pharma on Thursday reported 72% year-on-year (YoY) drop in net profit to Rs 79 crores in Q4FY23 due to production shutdown at one of ...
Gland Pharma to invest Rs 400 crore to expand its Telangana plantThe expanded site is envisaged to meet the national and international regulations to be followed in the manufacturing of the biological pro...
Buy Gland Pharma, target price Rs 1700: Motilal Oswal Financial ServicesGland Pharma, incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 22233.18 Crore) operating in Pharmaceuticals...
Gland Pharma acquires French CDMO Cenexi for €120 millionFounded in 2004, Cenexi, along with its subsidiaries, is engaged primarily in the business of CDMO of pharmaceutical products with expertis...
Gland Pharma Q2 PAT declines 20% YoY to Rs 241 croreGland Pharma's consolidated revenue from operations stood at Rs 1,044 crore as against Rs 1,080 crore in the same quarter a year ago
Gland Pharma plunges 12%, hits 52-week low on flop show in Q1The company's profit fell by 36.7 per cent year-on-year (YoY) to Rs 221.9 crore in the said quarter from Rs 350.65 crore in the same period...
Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
Gland Pharma expects to begin exports of single shot Sputnik Light vaccine by NovemberAs per RDIF, Sputnik Light has been authorized in more than 15 countries. Gland Pharma said it is focusing on rolling out the single shot S...
Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earningsDrug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter en...
Gland Pharma Q1 results: Net profit rises 12% to Rs 351 crConsolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...
Gland Pharma Q4 results: Net profit rises 34% to Rs 260 crConsolidated revenue from operations of the company stood at Rs 887.7 crore for the quarter under consideration. It was Rs 635.2 crore in t...
Dr Reddy's launches generic Invanz injection in US marketWe're excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr Reddys, has enabl...